Tirzepatide 2.5mg Prefilled Pen Injection

Product Introduction

Tirzepatide 2.5mg Prefilled Pen Injection is the initiation strength of once-weekly tirzepatide treatment. It introduces treatment gradually before escalation for type 2 diabetes or weight-management treatment in eligible adults.

How to use

After practical injection training, inject under the skin of the abdomen, thigh or upper arm once weekly, with or without food. Rotate sites and never share the pen or needles. If a dose is missed, it can be taken within four days; after four days, skip it and resume the usual day. Keep at least three days between doses when changing the weekly injection day.

How it works

Tirzepatide activates GIP and GLP-1 receptors, increasing glucose-dependent insulin release, reducing glucagon, slowing gastric emptying, and reducing appetite.

Side effects

Possible effects include nausea, vomiting, diarrhea, constipation, abdominal pain, reflux, burping, reduced appetite, and injection-site reactions. Serious concerns include pancreatitis, gallbladder disease, kidney injury from dehydration, severe GI reactions, hypoglycemia with insulin/sulfonylureas, thyroid tumor warning, and allergy.

Important information

Do not use with a personal or family history of medullary thyroid carcinoma or MEN2. Tell your doctor about type 1 diabetes, ketoacidosis, pancreatitis, gallbladder or kidney disease, severe digestive problems, diabetic retinopathy, other thyroid disease. Mention pregnancy plans, breastfeeding, insulin, sulfonylureas, oral contraception and planned anaesthesia. Learn the injection technique before home treatment. A non-oral contraceptive method or an additional barrier method is needed for four weeks after starting and for four weeks after each dose increase when oral hormonal contraception is used.